Loeb Partners Corp’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11
Closed -$13K 325
2018
Q4
$13K Sell
11
-21
-66% -$33.3K 0.01% 219
2018
Q3
$53K Sell
32
-21
-40% -$34.8K 0.02% 140
2018
Q2
$94K Buy
53
+21
+66% +$30.9K 0.02% 156
2018
Q1
$42K Hold
32
0.02% 121
2017
Q4
$26K Hold
32
0.01% 155
2017
Q3
$29K Hold
32
0.01% 162
2017
Q2
$37K Hold
32
0.01% 164
2017
Q1
$46K Hold
32
0.01% 159
2016
Q4
$45K Hold
32
0.02% 154
2016
Q3
$64K Hold
32
0.02% 149
2016
Q2
$74K Hold
32
0.02% 159
2016
Q1
$87K Hold
32
0.03% 146
2015
Q4
$122K Sell
32
-32
-50% -$107K 0.04% 148
2015
Q3
$229K Hold
64
0.08% 141
2015
Q2
$270K Hold
64
0.08% 147
2015
Q1
$265K Buy
64
+43
+205% +$156K 0.08% 152
2014
Q4
$58K Hold
21
0.02% 169
2014
Q3
$64K Buy
+21
New +$70.1K 0.02% 158

Other funds holding CFRX

Loeb Partners Corp's CFRX Position: Q1 2019 in Review

Loeb Partners Corp sold out of ContraFect Corporation (CFRX) in Q1 2019, closing a stake of 11 shares — an estimated $13K sold.

Loeb Partners Corp first reported a position in CFRX in Q3 2014 and held it in 18 quarters. The position peaked at $270K in Q2 2015. 37 funds tracked by Wall St. Rank hold CFRX as of Q1 2019.

  • Loeb Partners Corp reported no remaining ContraFect Corporation position as of Q1 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 11 ContraFect Corporation shares in Q1 2019, an estimated $13K.
  • Loeb Partners Corp first reported a position in ContraFect Corporation in Q3 2014 and held it in 18 quarters.
  • Loeb Partners Corp's ContraFect Corporation position peaked at $270K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.